Big Picture News, Informed Analysis

Canadian journalist Donna Laframboise. Former National Post & Toronto Star columnist, past vice president of the Canadian Civil Liberties Association.

300 Published Reports of Vaccine Linked Medical Problems

Eight Hispanic boys treated for heart inflammation at a Miami children’s hospital in 36 days. 18 reports of heart inflammation in Switzerland during the first half of 2021 – compared to six in the previous 9 years.

As explained in Part 1 here, there are now hundreds of medical journal reports describing fatal or life-altering events following COVID-19 vaccine injections.

Having discovered a list of 400+ such articles online, I’ve been taking a closer look. It’s been time-consuming working my way through that list, albeit in a more cursory manner than one might wish.

Below is the third batch of 100 articles. Sixteen turned out to be duplicates. So the ‘300’ in the title of this blog post is approximate.

Some aren’t especially illuminating. #226, for example, tells us no blood clots were observed among 521 people in Thailand who received their first dose of AstraZeneca and then had their blood tested within 30 days. Except that the researchers did find a blood clot. In a 76-year-old vaccinated woman. Which they proclaimed “was probably not related to vaccination.”

Article #233 was published online by the New England Journal of Medicine last October and is based on Israeli data. It concludes that teenage boys (16 to 19 years) have a 1 in 6,637 chance of developing heart inflammation after receiving their second dose of Pfizer. That’s a nine times higher risk than normal.

Article #244 tells us that, in Switzerland, medical professionals and pharmaceutical companies are “obliged by law to report the occurrence of [adverse drug and vaccine reactions] to the national regulatory authority.” During the previous nine years (2012 to 2020), heart inflammation was reported a total of six times. During the first half of 2021 it was reported 18 times. The article describes this as a “dramatic increase.”

Suspected cases of vaccine or drug-induced heart inflammation reported in Switzerland since 2012. The final bar represents only the first half of 2021’s data. Click image for source.

Article #258 reports on eight Hispanic boys, aged 15 to 17. All were treated for heart inflammation at a Miami children’s hospital during a 36-day period. Most had received two doses of Pfizer. After spending between 34 and 95 hours in hospital, they were all “discharged home with strict physical activity restrictions and cardiology follow-up.” If any of those boys were athletes working toward a college sports scholarship, that dream is now over.

Article #285 is a poignant description, by doctors in France, of their struggles to save the lives of two patients who suffered severe strokes after receiving the AstraZeneca vaccine. The patients landed in ICU within days of each other. In both instances, part of their skull was removed to alleviate brain swelling, but they died anyway.

In the list below, comments in red were added by me.


201. Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine? [stroke – Infection, July 2021]

202. Central venous sinus thrombosis with subarachnoid hemorrhage following an mRNA COVID-19 vaccination: are these reports merely co-incidental? [stroke – American Journal of Case Reports, Sept. 2021]

203. Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI: [stroke – Stroke and Vascular Neurology, July . 2021]

204. Early outcomes of bivalirudin therapy for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after Ad26.COV2.S Vaccination [stroke – Annals of Emergency Medicine, July 2021]

205. Cerebral venous sinus thrombosis associated with thrombocytopenia post-vaccination for COVID-19: [stroke – Critical Care, Apr. 2021]

206. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine: [stroke – Acta Neurochirurgica: The European Journal of Neurosurgery, June 2021]

207. Vaccine induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high fatality rate: a case series: [stroke – Frontiers in Neurology, July 2021]

208. Interactions of adenoviruses with platelets and coagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome: [blood clots – Haematologica, Dec. 2021]

209. Headache attributed to vaccination against COVID-19 (coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) vaccine: a multicenter observational cohort study: [headache – Pain and Therapy, July 2021]

210. Reported adverse effects following COVID-19 vaccination at a tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST): [stroke – Expert Review of Vaccines, Apr. 2021]

211. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency: [stroke – European Journal of Neurology, July 2021]

212. duplicate of #42 HERE

213. Arterial events, venous thromboembolism, thrombocytopenia and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population-based cohort study: [blood clots – British Medical Journal, May 2021]

214. Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: [stroke – Journal of Thrombosis and Thrombolysis, June 2021]

215. duplicate of #7 HERE

216. Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia: [stroke – Nature Communications, Aug. 2021]

217. Neurological side effects of SARS-CoV-2 vaccinations: [stroke – Acta Neurologica Scandinavica, Nov. 2021]

218. Coagulopathies after SARS-CoV-2 vaccination may derive from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-activated signaling pathways: [blood disorders – International Journal of Molecular Sciences, Oct. 2021]

219. Isolated pulmonary embolism following COVID vaccination: 2 case reports and a review of acute pulmonary embolism complications and follow-up: [blood clots – Journal of Community Hospital Internal Medicine Perspectives, Nov. 2021]

220. Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination: A case report: [vision problems – Indian Journal of Opthalmology, Oct. 2021]

221. Complicated long term vaccine induced thrombotic immune thrombocytopenia – A case report: [fatal brain bleed – Vaccines, Nov. 2021]

222. Deep venous thrombosis after Ad26.COV2.S vaccination in adult male: [blood clots – Case Reports in Critical Care, Oct. 2021]

223. Neurological autoimmune diseases after SARS-CoV-2 vaccination: a case series: [immune disorders – European Journal of Neurology, Oct. 2021]

224. Severe autoimmune hemolytic autoimmune anemia after receiving SARS-CoV-2 mRNA vaccine: [blood disorders – Transfusion, Sept. 2021]

225. Emergence of COVID-19 variants among ChAdOx1 nCoV-19 (recombinant) vaccine recipients: [vaccine failure – Indian Journal of Medical Research, May-June 2021]

226. Prevalence of thrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people after with ChAdOx1 nCoV-19 vaccination: [blood clots – Research and Practice in Thrombosis and Haemostasis, Sept. 2021]

227. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccination: [heart inflammation – Clinical Infectious Diseases, Nov. 2021]

228. Myocarditis following coronavirus disease 2019 mRNA vaccine: a case series and incidence rate determination: [heart inflammation – Clinical Infectious Diseases, Nov. 2021]

229. Myocarditis and pericarditis following COVID-19 vaccination: inequalities in age and vaccine types: [heart inflammation – Journal of Personalized Medicine, Oct. 2021]

230. Epidemiology and clinical features of myocarditis/pericarditis before the introduction of COVID-19 mRNA vaccine in Korean children: a multicenter study: [heart inflammation – Journal of Korean Medical Science, Aug. 2021]

231. Shedding the light on post-vaccine myocarditis and pericarditis in COVID-19 and non-COVID-19 vaccine recipients: [heart inflammation – Vaccines, Oct. 2021]

232. Myocarditis Following mRNA COVID-19 Vaccine: [heart inflammation – Pediatric Emergency Care, Nov. 2021]

233. Myocarditis following BNT162b2 mRNA Covid-19 mRNA vaccine in Israel: [heart inflammation – New England Journal of Medicine, Oct. 2021]

234. Myocarditis, pericarditis, and cardiomyopathy following COVID-19 vaccination: [heart inflammation – Heart Lung and Circulation, Aug. 2021]

235. duplicate of #110 HERE

236. duplicate of #70 HERE

237. Hypersensitivity Myocarditis and COVID-19 Vaccines: [heart inflammation – Kardiologia Polka, Polish Heart Journal, Dec. 2021]

238. Severe myocarditis associated with COVID-19 vaccine: zebra or unicorn? [heart inflammation – International Journal of Cardiology, Sept. 2021]

239. Acute myocardial infarction and myocarditis after COVID-19 vaccination: [heart inflammation – QJM: International Journal of Medicine, Sept. 2021]

240. Myocarditis after Covid-19 vaccination in a large healthcare organization: [heart inflammation – New England Journal of Medicine, Dec. 2021]

241. duplicate of #2 HERE

242. Clinically suspected myocarditis temporally related to COVID-19 vaccination in adolescents and young adults: [heart inflammation – Circulation, Dec. 2021]

243. STEMI mimic: focal myocarditis in an adolescent patient after mRNA COVID-19 vaccine: [heart inflammation – Journal of Emergency Medicine, Dec. 2021]

244. Myocarditis and pericarditis in association with COVID-19 mRNA vaccination: cases from a regional pharmacovigilance center: [heart inflammation – Global Cardiology Science & Practice, Oct. 2021]

245. Myocarditis after COVID-19 mRNA vaccines: [heart inflammation – QJM: International Journal of Medicine, Sept. 2021]

246. Patients with acute myocarditis after mRNA COVID-19 vaccination: [heart inflammation – JAMA Cardiology, June 2021]

247. Myocarditis after COVID-19 vaccination: a case series: [heart inflammation – Vaccine, Oct. 2021]

248. duplicate of #66 HERE

249. Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents: [heart inflammation – American Journal of Roentgenology, Oct. 2021]

250. Myocarditis following COVID-19 vaccination: magnetic resonance imaging study: [heart inflammation – European Heart Journal – Cardiovascular Imaging, Nov. 2021]

251. Acute myocarditis after administration of the second dose of BNT162b2 COVID-19 vaccine: [heart inflammation – Cureus, Oct. 2021]

252. Myocarditis after COVID-19 vaccination: [heart inflammation – International Journal of Cardiology: Heart & Vasculature, Oct. 2021]

253. Case report: probable myocarditis after Covid-19 mRNA vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy: [heart inflammation – Frontiers in Cardiovascular Medicine, Oct. 2021]

254. Acute myocarditis after administration of BNT162b2 vaccine against COVID-19: [heart inflammation – Revista Espanola de Cardiologia, Sept. 2021]

255. Myocarditis associated with COVID-19 mRNA vaccination: [heart inflammation – Radiology, July 2021]

256. Acute myocarditis after COVID-19 vaccination: a case report: [heart inflammation – La Reveue de Médecine Interne, Nov. 2021]

257. Acute myopericarditis after COVID-19 vaccination in teenagers: [heart inflammation – Case Reports in Cardiology, Sept. 2021]

258. Perimyocarditis in adolescents after Pfizer-BioNTech COVID-19 vaccination: [heart inflammation – Journal of the Pediatric Infectious Diseases Society, July 2021]

259. Acute myocarditis associated with anti-COVID-19 vaccination: [heart inflammation – Clinical and Experimental Vaccine Research, May 2021]

260. Myocarditis associated with COVID-19 vaccination: echocardiography, cardiac tomography, and magnetic resonance imaging findings: [heart inflammation – Circulation: Cardiovascular Imaging, Aug. 2021]

261. duplicate of #25 HERE

262. Myocarditis and pericarditis in adolescents after first and second doses of COVID-19 mRNA vaccines: [brain – European Heart Journal – Quality of Care and Clinical Outcomes, Nov. 2021]

263. COVID 19 vaccine for adolescents. Concern about myocarditis and pericarditis: [heart inflammation – Pediatric Reports, Sept. 2021]

264. Cardiac imaging of acute myocarditis following COVID-19 mRNA vaccination: [heart inflammation – Journal of Korean Medical Science, Aug. 2021]

265. duplicate of #65 HERE

266. Acute myocardial injury after COVID-19 vaccination: a case report and review of current evidence from Vaccine Adverse Events Reporting System database: [heart inflammation – Journal of Primary Care & Community Health, July 2021]

267. Acute myocarditis associated with COVID-19 vaccination: a case report: [heart inflammation – Journal of Cardiology Cases, Dec. 2021]

268. Myocarditis following vaccination with COVID-19 messenger RNA: a Japanese case series: [heart inflammation – Internal Medicine, Japanese Society of Internal Medicine, Nov. 2021]

269. Myocarditis in the setting of a recent COVID-19 vaccination: [heart inflammation – Case Reports in Cardiology, Oct. 2021]

270. Acute myocarditis after a second dose of the mRNA COVID-19 vaccine: a report of two cases: [heart inflammation – Cardiothoracic Imaging, June 2021]

271. duplicate of #226 above

272duplicate of #227 above

273duplicate of #228 above

274. duplicate of #229 above

275duplicate of #230 above

276. duplicate of #231 above

277. Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: case report: [blood clots – Journal of Medical Case Reports, Oct. 2021]

278. duplicate of #5 HERE

279. Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination: [stroke- British Medical Journal, Sept. 2021]

280. CAd26.COV2-S vaccination can reveal inherited thrombophilia: massive cerebral venous sinus thrombosis in a young man with normal platelet count: [stroke – Polish Archives of Internal Medicine, Oct. 2021]

281. duplicate of #23 HERE

282. COVID-19 vaccine-induced thrombosis: [blood clots- International Journal of Tuberculosis and Lung Disease, Sept. 2021]

283. Inflammation and platelet activation after COVID-19 vaccines – possible mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis: [blood clots- Frontiers in Immunology, Nov. 2021]

284. mRNA COVID-19 vaccine-related anaphylactoid reaction and coronary thrombosis: [heart inflammation – Mayo Clinic Proceedings, Oct. 2021]

285. Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopenia: A missed opportunity for rapid return of experience: [stroke – Anaesthesia Critical Care & Pain Medicine, Aug. 2021]

286. Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis: [blood clot – BMJ Case Reports, Dec. 2021]

287. Deep vein thrombosis more than two weeks after vaccination against COVID-19: [blood clots – Tidsskriftet, Journal of the Norwegian Medical Association, Apr. 2021]

288. Guillain-Barré syndrome after COVID-19 vaccination in an adolescent: [nerve disorder – Pediatric Neurology, Oct. 2021]

289. Guillain-Barré syndrome following ChAdOx1-S/nCoV-19 vaccine: [nerve disorder – Annals of Neurology, June. 2021]

290. Guillain-Barré syndrome after COVID-19 mRNA-1273 vaccine: case report: [nerve disorder – Acta Neurologica Belgica, Belgian Neurological Society, July 2021]

291. Post SARS-CoV-2 vaccination Guillain-Barré syndrome in 19 patients: [nerve disorder – Clinics (Sao Paulo), Sept. 2021]

292. Guillain-Barré syndrome presenting with facial diplegia following COVID-19 vaccination in two patients: [nerve disorder – BMJ Case Reports, Oct. 2021]

293. A rare case of Guillain-Barré syndrome following COVID-19 vaccination: [nerve disorder – European Journal of Case Reports in Internal Medicine, Sept. 2021]

294. Neurological complications of COVID-19: Guillain-Barré syndrome following Pfizer COVID-19 vaccine: [nerve disorder – Cureus, Feb. 2021]

295. COVID-19 vaccine causing Guillain-Barré syndrome, a rare potential side effect: [nerve disorder – Clinical Case Reports, Aug. 2021]

296. Guillain-Barré syndrome after first vaccination dose against COVID-19: case report: [nerve disorder – Acta Medica, Czech Republic, 2021]

297. Miller Fisher syndrome after Pfizer COVID-19 vaccine: [nerve disorder – Nuerological Sciences, Nov. 2021]

298.  Miller Fisher syndrome after 2019 BNT162b2 mRNA coronavirus vaccination: [nerve disorder – BMC Neurology, Nov. 2021]

299. Bilateral facial weakness with paresthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine: [nerve disorder – Journal of Neurology, Neurosurgery & Pschiatry, July 2021]

300. Guillain-Barré syndrome following first injection of ChAdOx1 nCoV-19 vaccine: first report: [nerve disorder – Revue Neurologique, Dec. 2021]





This blog isn’t cluttered with intrusive ads –
which means no income is earned in that manner.
If what you’ve just read is useful or helpful,
please consider making a donation

please support this blog






Print Friendly, PDF & Email


This entry was posted on January 26, 2022 by in ethical & philosophical, health, Uncategorized and tagged .
%d bloggers like this: